journal article·2022-05-18

A Bio-Inorganic Hybrid Hemostatic Gauze for Effective Control of Fatal Emergency Hemorrhage in “Platinum Ten Minutes”

Lisha Yu, Hongliang Zhang, Liping Xiao, Jie Fan, Tanshi Li

ACS Applied Materials & Interfaces· Volume 14· Issue 19
Publisher page

Abstract

Death from massive hemorrhage represents a global problem. It is a challenging task to design hemostatic materials with significant efficacy, good biocompatibility, reliable safety, and high stability. In this study, we demonstrate an effective bio-inorganic hybrid hemostat fabricated by stepwise procedures of on-site growth of zeolite gauze and immobilization of trypsin on the zeolite gauze. The as-synthesized hybrid hemostat catalyzes the transition of prothrombin-to-thrombin and exhibits excellent procoagulant performance in the both normal plasma and FX-deficient plasma. The hemostatic treatment of junctional femoral artery rupture in the porcine model confirms that this hybrid hemostat manifests itself with superior hemostatic performance over commercial hemostatic dressings, in terms of a reduced time to hemostasis and blood loss. The stability of the hybrid hemostat is validated through high temperature and violent shaking evaluation. This bio-inorganic hybrid hemostat displays high procoagulant activity, low cytotoxicity, and extended shelf life which may achieve the "Platinum Ten Minutes" rescue in battlefield and traffic accident medicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemostasis and retained surgical items · Surgical Sutures and Adhesives · Trauma, Hemostasis, Coagulopathy, Resuscitation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Lab of Applied Chemistry of Zhejiang Province, Department of Chemistry, Zhejiang University, Hangzhou 310027, China

Medical School of Chinese People’s Liberation Army (PLA), Beijing 100853, China

Department of Emergency, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (36)

Show source-provided references
1. 10.1016/S0140-6736(12)61728-010.1016/S0140-6736(12)61728-0 ↗
2. 10.1056/NEJMra170564910.1056/NEJMra1705649 ↗
3. 10.1038/s41467-019-13512-810.1038/s41467-019-13512-8 ↗
4. 10.1016/j.injury.2014.08.04310.1016/j.injury.2014.08.043 ↗
5. 10.1136/emj.2004.02261610.1136/emj.2004.022616 ↗
6. 10.1038/s41467-018-04998-910.1038/s41467-018-04998-9 ↗
7. 10.1038/s41467-019-10290-110.1038/s41467-019-10290-1 ↗
8. 10.1038/s41467-021-24972-210.1038/s41467-021-24972-2 ↗
9. 10.1097/SLA.0b013e3181c3bcca10.1097/SLA.0b013e3181c3bcca ↗
10. 10.7205/milmed-d-13-0019910.7205/milmed-d-13-00199 ↗
11. 10.1016/j.msec.2015.09.00810.1016/j.msec.2015.09.008 ↗
12. 10.1002/adma.20170085910.1002/adma.201700859 ↗
13. 10.1039/D0TB00906G10.1039/D0TB00906G ↗
14. 10.1038/s41570-021-00323-z10.1038/s41570-021-00323-z ↗
15. 10.1097/SLA.0b013e3181c3bcca10.1097/SLA.0b013e3181c3bcca ↗
16. 10.1001/archsurg.133.1.3210.1001/archsurg.133.1.32 ↗
17. 10.1097/00005373-199901000-0000910.1097/00005373-199901000-00009 ↗
18. Kheirabadi B. · US Army Med. Dep. J. · 2011 · 2 · 25
19. 10.1097/00005373-200301000-0002310.1097/00005373-200301000-00023 ↗
20. 10.1038/s41467-019-09849-910.1038/s41467-019-09849-9 ↗
21. 10.1097/TA.0b013e3181c97ef110.1097/TA.0b013e3181c97ef1 ↗
22. 10.1111/j.1553-2712.2011.01036.x10.1111/j.1553-2712.2011.01036.x ↗
23. 10.1097/TA.0b013e3181ac0c9910.1097/TA.0b013e3181ac0c99 ↗
24. 10.1097/01.ta.0000127763.90890.3110.1097/01.ta.0000127763.90890.31 ↗
25. 10.1097/TA.0b013e318275566210.1097/TA.0b013e3182755662 ↗
26. 10.1038/s41929-021-00654-610.1038/s41929-021-00654-6 ↗
27. 10.1007/s12274-021-3394-z10.1007/s12274-021-3394-z ↗
28. 10.1111/jth.1221710.1111/jth.12217 ↗
29. 10.1182/blood-2012-08-37893510.1182/blood-2012-08-378935 ↗
30. 10.1007/s12274-014-0505-010.1007/s12274-014-0505-0 ↗
31. 10.1097/01.ta.0000240597.42420.8f10.1097/01.ta.0000240597.42420.8f ↗
32. 10.1097/TA.0b013e31819634a110.1097/TA.0b013e31819634a1 ↗
33. 10.1016/j.jemermed.2009.02.01710.1016/j.jemermed.2009.02.017 ↗
34. 10.1016/j.jss.2020.12.04010.1016/j.jss.2020.12.040 ↗
35. 10.1186/s13054-018-2171-110.1186/s13054-018-2171-1 ↗
36. 10.1016/j.jss.2019.09.06010.1016/j.jss.2019.09.060 ↗